Please login to the form below

Not currently logged in

diabetic macular oedema

This page shows the latest diabetic macular oedema news and features for those working in and with pharma, biotech and healthcare.

Bicycle Therapeutics looks to raise $86m with IPO

Bicycle Therapeutics looks to raise $86m with IPO

The lead molecule of this partnership is THR-149, a novel plasma kallikrein inhibitor, for the treatment of diabetic macular oedema.

Latest news

More from news
Approximately 3 fully matching, plus 24 partially matching documents found.

Latest Intelligence

  • Diagnosed Anywhere Diagnosed Anywhere

    The system creates an immediate, reliable assessment for diabetic retinopathy, including macular oedema, during a routine office visit in a primary care setting. ... The diagnostic report includes treatment advice aligned with the American Academy of

  • Medius Deal Watch table for February 2015 Medius Deal Watch table for February 2015

    Majority acquisition. 380. Pfenex/ Hospira. PF582 -  LUCENTIS biosimilar candidate - wet age-related macular degeneration, diabetic macular oedema.

  • Allergan and taking a specialised approach Allergan and taking a specialised approach

    spasticity associated with stroke and for the ophthalmology treatment Ozurdex in diabetic macular oedema.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company

Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....